Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer’s Disease Continuum
Authors (first, second and last of 12)
Collection
Use of blood biomarker in Alzheimer’s clinical trials
The Journal of Prevention of Alzheimer’s Disease is looking for outstanding articles linking blood biomarkers and Alzheimer drug development. Results for screening as well as disease progression measurement or impact of drug are welcome.
The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if the guest editor(s) authors an article in their special issue, they will not handle the peer review process.
Editors
-
Jacques Touchon
Jacques Touchon, University Montpellier, Montpellier, France.
